Pharmaceutical / Drug Definition :
Reacts in kidney with urotoxic ifosfamide metabolites (acrolein and 4-hydroxy-ifosfamide), resulting in their detoxification. Also binds to double bonds of acrolein and to other urotoxic metabolites.
In the United States, Mesna is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Mesna.
Registrar Corp assists Mesna companies with:
FDA Label Requirements and Exceptions
FDA Import Information
Mesna (Mesna Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Mesna (Mesna Suppliers)
- Processors Mesna
- Repackers Mesna
- Relabelers Mesna
- Exporters Mesna
- Importers Mesna
For more information about Mesna, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.